For instance, in ESCC, elevated NSUN2 levels are associated with advanced tumor stages and reduced patient survival, emphasizing its potential as a prognostic marker (Niu et al., 2022; Su et al., 2021). This evidence concerns the gene NSUN2 and neoplasm.